Liquisolid Systems: A Review
DOI:
https://doi.org/10.37285/ijpsn.2010.3.1.1Abstract
Liquisolid technique is a new and promising method that can change the dissolution rate of water insoluble drugs. According to the new formulation method of liquisolid compacts, liquid medications such as solutions or suspensions of water insoluble drugs in suitable non-volatile liquid vehicles can be converted into acceptably flowing and compressible powders by blending with selected powder excipients. It has been speculated that such systems exhibit enhanced release profiles. In this case, even though the drug is in a solid dosage form, it is held within the powder substrate in solution or, in a solubilized, almost molecularly dispersed state, which contributes to the enhanced drug dissolution properties.
Downloads
Metrics
Keywords:
Liquisolid compacts, Liquid medication, mathematical model, liquid load factor (Lf)
Downloads
Published
How to Cite
Issue
Section
References
Bhandari S, Mittapalli RK, Gannu R et al., Orodispersible tablets: An overview, Asian J Pharm, 1-11 (2008).
Charman SA, Charman WN. Oral modified release delivery systems, In: Rathbone MJ, Hadgraftb J, Roberts MS. Modified Release Drug Delivery Technology, New York, 2003, pp.1-9.
Cole ET, liquid filled and sealed hard gelatin capsule technologies, In: Rathbone MJ, Hadgraftb J, Roberts MS. Modified Release Drug Delivery Technology, New York, Marcel Dekker Inc, 2003, P.177-190.
Darwish AM., El-Kamel AH. Dissolution enhancement of glibenclamide using liquisolid tablet technology, Acta Pharm. 51: 173-181(2001).
El-Zein H, Riad L, El-Bary A, Enhancement of carbmazepine dissolution In vitro and In vivo evaluation, Int. J. Pharm. 168: 209–220 (1998).
Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablet formulation: In vitro and In vivo evaluation, Eur. J. Pharm. Biopharm. 69: 993-1003 (2008).
Ghorab MM, Abdel-Salam HM, El-Sayad MA, et al., Tablet formulation containing meloxicam and β-cyclodextrin: mechanical characterization and bioavailability evaluation, AAPS Pharm Sci Tech, 5: 1-6 (2004).
Gowrishankar P, Ali M, Baboota S. Preparation and properties of valdecoxib– hydroxypropyl-β-cyclodextrin inclusion complex, PDA. 61: 175-182 (2007).
Javadzadeh Y, Musaajrezaei L, Nokhodchi A., Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices, Int. J. Pharm. 102-108 ( 2008).
Javadzadeh Y, Navimipour B, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water insoluble drug (carbamazepine), Int. J. Pharm. 341: 26-34 (2007)
Javadzadeh Y, Shariati H, Movahhed-danesh E, et al., Effects of different grades of microcrystalline cellulose on flowability, compressibility and dissolution of liquisolid systems, Drug. Dev. Ind. Pharm. 1-9 (2008)
Javadzadeh Y, Siahi MR, Asnaashri S, et al., An investigation of physicochemical properties of piroxicam liquisolid compacts, Pharm. Dev. Tech. 12: 337-34. (2007).
Javadzadeh Y, Siahi MR, Asnaashri S, et al., Enhancement of dissolution rate of piroxicam using Liquisolid compacts, IL Farmaco. 60: 361-365 (2005).
Javadzadeh Y, Siahi MR, Barzegar-Jalali M, et al., The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts, J Pharm pharmaceut Sci, 8: 18- 25 (2005).
Kapsi SG, Ayres JW, Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability, Int. J. Pharm., 29: 193–203 (2001).
Khaled KA, Asiri YA, El-sayed YM. In vivo evaluation of hydrochlorothiazide liquisolid tablets in beagle dogs, Int. J. Pharm. 222: 1-6 (2001).
Li XS, Wang JX, Shen ZG, et al., Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method, Int. J. Pharm. 342: 26–32 (2007).
Munke AP, Nagarsenker MS. Triamterene β-cyclodextrin complexes: Preparation, characterization and In vivo evaluation, AAPS PharmSciTech, 5: 1-9 (2004).
Nazzal S, Khan MA, Controlled release of a self-emulsifying formulation from a tablet dosage form: Stability assessment and optimization of some processing parameters, Int. J. Pharm., 315: 110–121 (2006).
Nazzal S., Nutan M., Palamakula A., Optimization of a self-nanoemulsified tablet dosage form of ubiquinone using response surface methodology: Effect of formulation ingredients, Int. J. Pharm., 240: 103–114 (2002).
Nighute AB, Bhise S B, Enhancement of dissolution rate of rifabutin by preparation of microcrystals using solvent change method, Int. J. PharmTech. Res. 1: 142-148 (2009).
Patel VP, Patel NM, Dissolution enhancement of glipizide using liquisolid tablet technology, Indian Drugs. 45(4): 318-323(2008).
Patil1 P, Paradkar A, porous polystyrene beads as carriers for self-emulsifying system containing loratadine, AAPS PharmSciTech, 7: E1-E7 (2006).
Rakshit P, Ridhish P, Moinuddin S, et al., Formulation and evaluation of liquisolid compacts of piroxicam, Ind drugs, , 44: 967-972 (2007).
Rane Y, Mashru R, Sankalia M, Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology, AAPS PharmSciTech. 8: E1-E11 (2007).
Setty CM, Prasad D.V.K, Gupta RM, et al., Development of fast dispersible aceclofenac tablet: effect of functionality of super disintegrants, Indian J. Pharm. Sci, 70: 180-185 (2008)
Shah TJ, Amin AF, Parikh JR, et al., Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug, AAPS PharmSciTech. 8: E1-E7 (2007).
Shinde AJ. Solubilization of poorly soluble drugs: A review, available at http://www.pharmainfo.net/reviews/solubilization -poorly-soluble-drugs-review (2007).
Spiras S, Bolton SM. Liquisolid systems and methods for preparing same, United States patent 6,096,337, (2000).
Spiras S, Bolton SM. Liquisolid systems and methods for preparing same, United States patent 5,968,550, (1999).
Spiras S, Wang T, Grover R. Effect of powder substrate on dissolution properties of methylclothiazide Liquisolid compacts, Drug. Dev. Ind. Pharm. 25: 63-168 (1999).
Spiras S. Liquisolid systems and methods for preparing same, United States patent 6,423,339 B1, (2002).
Spireas S, Sadu S, Grover R. In vitro release evaluation of hydrocortisone liquisolid tablets, J. Pharm. Sci. 87: 867-872 (1998)
Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int. J. Pharm. 166: 177-188 (1998)
Staniforth J., Powder flow, In: M. Aulton, Pharmaceutics: the Science of Dosage Form Design, Edinburgh, 2002, pp. 197–210.
Tayel SA, Soliman I, Louis D. Improvement of dissolution properties of carbamazepine through application of the liquisolid tablet technique, Eur. J. Pharm. Biopharm. 69: 342-347 (2008).
Vanshiv SD, Rao MRP, Sonar GS et al., Physicochemical characterization and in vitro dissolution of domperidone by solid dispersion technique, Indian. J. Phar. Edu. Res. 43: 86-90 (2009).
Wells J. Pharmaceutical Preformulation: The physicochemical properties of drug substances, In: Aulton M, Pharmaceutics: the Science of Dosage Form Design, Edinburgh, 2002, pp.114-138.
